The Island

The Island

ICO Ended
11,559 Views
We are making for you a game, which does not limit you in choosing the path. Your goal is to survive at any cost in the world that wants to kill you and is very inventive in realizing this desire. So who is stronger? Will you be able to bend the world.
2.8
TOTAL SCORE
3.5
ICO PROFILE

(weight: 45%)

1
TEAM PROOF

(weight: 20%)

Get widget
General
Website: Visit
White paper: Read
ICO Time: 28 Aug 2017 - 25 Sept 2017
Token info
Ticker: LDM
Financial
Raised $ 7,401
ICO Price: 0.2074 USD
Q3 2017
Release of the alpha version of the game (single-player) for closed testing.
Q4 2017
Release of the beta version (single-player) for open testing, the beginning of development of multiplayer version, development of the design document, the involvement of the first partners in the field of external integration of LDM tokens.
Q1 2018
The creation of the first infrastructural near-game project - the exchange service, the output of the single-player version of the game on Steam, the involvement of the letsplayers in the advertising of the single-version of the game.
Q2 2018
Closed alpha testing of the multiplayer version of the game in a small location (arena mode), the end of the second quarter - open testing of the arena mode.
Q3 2018
Launch of the second infrastructure project: donation-service for donating to the letsplayers without commission with the use of LDM tokens, attracting flyers to advertising the donation-service with the creation of unique conditions for them.
Q4 2018
Release multiplayer version of the game (with the open world) in an open beta test.
Screenshots taken on 25 Apr 2018
Den Semenov
Founder, Game-design
No participating data
Den Pechenkin
No participating data
Michael Krasakov
No participating data
Anton Ludashov
No participating data

Advisors (0)

HEIGHT - 0px
WIDTH - 0px
PUT THIS CODE TO YOUR WEBSITE
ICO List
Other Interesting ICOs
Upcoming
Collectible
Collectible is the exclusive NFT + Physical Item online platform out there. It’s one of a kind. Just like its items. With different unannounced drops happening every week ranging from sport memorabilia to long century old art brought back to life through our NFT creating process making it relevant again. Through our top-notch blockchain technology and NFT creating service we provide a level of authenticity to users that hasn't been seen since the beginning of the internet.
Upcoming
MeconCash
We intend to develop MeconCash into a platform that allows user’s assets to be transferred and traded between different types of services by integrating point reward systems, contents purchase, and settlement, which are currently operated separately between existing services and those under development. To that end, we will build the reward and settlement system, develop the API to connect it with other services, and build an ecosystem that can be used in the on- and off-line real economy. All this will ensure the usability, connectivity, and sustainability of MeconCash. We will develop a variety of mobile-based applications, games, and contents on the platform and link it with such services as online marketplaces where users can purchase products. The reward system used by a service generally invalidates the rewards owned by users when the service is terminated. MeconCash, however, can transform the rewards obtained from using our services into valuable assets. As such, users will be able to fulfill the demand for new services with MeconCash even when the services they use are terminated, make transactions between them, and use the assets in the real economy. We will stabilize the MeconCash ecosystem by developing new blockchain-based businesses and linking it with external services which already exists. Additionally, MeconCash will be available in 70% of ATMs in Korea so that users can directly withdraw MeconCash to fiat money.
Upcoming
Cryptelo
Cryptelo is a blockchain-based encryption technology company that provides data transfer, collaboration, versioning, and storage services. Cryptelo Platform technology combines encryption and blockchain based key management that allows for data mirroring. This means users can share data by giving access, without it ever leaving their hands, and no third party can access and read data without permission.
Upcoming
Talentchain
TalentChain, powered by Blockchain, bridges the prevalent trust deficit among students, universities, employees, recruiters and govt bodies, and serves as a single source of truth for all the stakeholders. It enables considerable and tangible cost reduction in qualifying learning and education admissions, recruitment and related statutory processes. Talentchain is a unique presentation of the knowledge asset that is securely verifiable and endorsable across various stakeholders.
Upcoming
Vidy
Vidy is the world's first decentralized ad network, powered by the ethereum blockchain. Vidy's ad platform allows advertisers to embed video ads directly into hyper-relevant website text, improving user experience, ad conversions and publisher payments. With just a hold, users can now reveal tiny hyper-relevant videos embedded in the text of any page on the web, unlocking a whole new dimension of the internet. All ads are placed with an NLP consensus protocol driven by miners. With a team of veteran engineers, industry-leading advisors and world-class brand partners, Vidy is on it's way to reinventing online advertising, e-commerce, and entertainment.
Upcoming
Pharmeum
Pharmeum is the world's first blockchain-based prescription platform with AI health analytics, which is currently working alongside the National Health Service (NHS) in England. The Pharmeum platform is an inter-operable, decentralised, digital prescription platform running over an intelligent neural network. Empowering patients’ ownership of their medication history, and enabling affordable access to healthcare globally. Medical errors and late diagnoses are minimised by using a permissioned blockchain integrated with artificial intelligence. Pharmeum is an advanced, digitised, health eco-system.The Pharmeum blockchain will improve medicine affordability, minimise errors, and create frictionless, quality care for patients.